81 related articles for article (PubMed ID: 8334261)
1. [31P-cardio-MR-spectroscopy in myocardial insufficiency].
Krahe T; Schindler R; Neubauer S; Ertl G; Horn M; Lackner K
Rofo; 1993 Jul; 159(1):64-70. PubMed ID: 8334261
[TBL] [Abstract][Full Text] [Related]
2. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
3. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
[TBL] [Abstract][Full Text] [Related]
4. MR spectroscopy of the heart.
Sardanelli F; Quarenghi M
Radiol Med; 2006 Dec; 111(8):1025-34. PubMed ID: 17171530
[TBL] [Abstract][Full Text] [Related]
5. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
6. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging.
Caus T; Kober F; Marin P; Mouly-Bandini A; Quilici J; Métras D; Cozzone PJ; Bernard M
Eur J Cardiothorac Surg; 2006 Jan; 29(1):45-9. PubMed ID: 16343922
[TBL] [Abstract][Full Text] [Related]
8. [In-vivo 31P-NMR-spectroscopy in patients with dilated cardiomyopathy].
Kaiser WA; Pauleit D; Träber F; Köhler U; Reiser M
Rofo; 1992 Nov; 157(5):458-65. PubMed ID: 1421186
[TBL] [Abstract][Full Text] [Related]
9. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
[TBL] [Abstract][Full Text] [Related]
10. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
Brinkmann G; Melchert UH; Lalk G; Heller M
Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
[TBL] [Abstract][Full Text] [Related]
11. [In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results].
Krahe T; Schindler R; Neubauer S; Hillenbrand H; Lackner K; Boesiger P; McKinnon G; Landwehr P; Ertl G
Rofo; 1991 Dec; 155(6):506-12. PubMed ID: 1764590
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial lipids and creatine measured by magnetic resonance spectroscopy among patients with heart failure].
Winter JL; Castro P; Meneses L; Chalhub M; Verdejo H; Greig D; Gabrielli L; Chiong M; Concepción R; Mellado R; Hernández C; Uribe S; Lavandero S
Rev Med Chil; 2010 Dec; 138(12):1475-9. PubMed ID: 21526294
[TBL] [Abstract][Full Text] [Related]
13. [Localized 31 phosphorus NMR spectroscopy of the human heart--development of a measuring method and initial clinical application].
Friedrich M; Weikl A; Sauter R; Reinhardt ER; Bachmann K
Z Kardiol; 1991 Apr; 80(4):266-71. PubMed ID: 1862667
[TBL] [Abstract][Full Text] [Related]
14. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
[TBL] [Abstract][Full Text] [Related]
16. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
Neubauer S; Horn M; Pabst T; Gödde M; Lübke D; Jilling B; Hahn D; Ertl G
Eur Heart J; 1995 Dec; 16 Suppl O():115-8. PubMed ID: 8682076
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study.
Schneider-Gold C; Beer M; Köstler H; Buchner S; Sandstede J; Hahn D; Toyka KV
Muscle Nerve; 2004 Nov; 30(5):636-44. PubMed ID: 15452841
[TBL] [Abstract][Full Text] [Related]
18. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of human cardiac 31P-NMR spectroscopy.
Lamb HJ; Doornbos J; den Hollander JA; Luyten PR; Beyerbacht HP; van der Wall EE; de Roos A
NMR Biomed; 1996 Aug; 9(5):217-27. PubMed ID: 9068003
[TBL] [Abstract][Full Text] [Related]
20. Cardiac MR spectroscopy in the new millennium.
Pohost GM; Meduri A; Razmi RM; Rathi VK; Doyle M
Rays; 2001; 26(1):93-107. PubMed ID: 11471351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
